We are live on
!
Find out more
HCM
Hillman Capital Management Portfolio holdings
AUM
$138M
1-Year Est. Return
8.57%
This Fund
S&P 500
This Quarter
Est. Return
-0.69%
1 Year Est. Return
+8.57%
3 Year Est. Return
+20.19%
5 Year Est. Return
+18.79%
10 Year Est. Return
–
AUM
$203M
AUM Growth
-$66.3M
(-25%)
Cap. Flow
-$62.6M
Cap. Flow
% of AUM
-30.81%
Top 10 Holdings %
Top 10 Hldgs %
32.69%
Holding
57
New
3
Increased
12
Reduced
36
Closed
6
Avg Time Held
12.1
quarters
Top 10 Avg Time Held
1.1
quarters
Top 20 Avg Time Held
6.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$3.98M |
| 2 |
Constellation Brands
STZ
|
+$3.76M |
| 3 |
Hershey
HSY
|
+$3.57M |
| 4 |
Advanced Micro Devices
AMD
|
+$3.56M |
| 5 |
Brown-Forman Class B
BF.B
|
+$1.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$10.7M |
| 2 |
AT&T
T
|
+$4.69M |
| 3 |
Intel
INTC
|
+$3.67M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.65M |
| 5 |
Boeing
BA
|
+$3.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.82% |
| 2 | Consumer Staples | 22.24% |
| 3 | Communication Services | 14.94% |
| 4 | Technology | 13.35% |
| 5 | Materials | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
AT&T
T
$166B
| $7.46M | 3.67% |
263,773
-186,403
| -41% | -$4.69M |
2013 Q3
46 quarters
|
|
2
Warner Bros
WBD
$77.6B
| $7.06M | 3.47% |
658,034
-264,540
| -29% | -$2.77M |
2021 Q2
15 quarters
|
|
3
CVS Health
CVS
$111B
| $6.81M | 3.35% |
100,450
-19,186
| -16% | -$1.15M |
2019 Q4
21 quarters
|
|
4
Zimmer Biomet
ZBH
$17.5B
| $6.63M | 3.26% |
58,557
-20,382
| -26% | -$2.18M |
2021 Q3
14 quarters
|
|
5
CarMax
KMX
$7.79B
| $6.55M | 3.22% |
84,101
-29,768
| -26% | -$2.39M |
2022 Q2
11 quarters
|
|
|
6
Brown-Forman Class B
BF.B
$12.1B
| $6.46M | 3.18% |
190,279
+44,106
| +30% | +$1.49M |
2024 Q4
1 quarter
|
|
|
7
Boeing
BA
$152B
| $6.4M | 3.15% |
37,538
-19,560
| -34% | -$3.39M |
2020 Q2
19 quarters
|
|
8
GSK
GSK
$93.3B
| $6.4M | 3.15% |
165,143
-66,008
| -29% | -$2.42M |
2020 Q4
17 quarters
|
|
9
AB InBev
BUD
$147B
| $6.39M | 3.15% |
103,850
-16,573
| -14% | -$907K |
2019 Q4
21 quarters
|
|
10
Estee Lauder
EL
$33.8B
| $6.29M | 3.09% |
95,274
-9,364
| -9% | -$677K |
2023 Q4
5 quarters
|
|
11
International Flavors & Fragrances
IFF
$21.2B
| $6.27M | 3.08% |
80,773
-17,767
| -18% | -$1.47M |
2023 Q2
7 quarters
|
|
12
DuPont de Nemours
DD
$17.6B
| $6.25M | 3.08% |
66,715
-22,432
| -25% | -$2.19M |
2019 Q4
21 quarters
|
|
13
The Kraft Heinz Company
KHC
$25.9B
| $6.24M | 3.07% |
204,998
-42,318
| -17% | -$1.27M |
2019 Q4
21 quarters
|
|
14
Baxter International
BAX
$12.5B
| $6.23M | 3.07% |
182,012
-22,059
| -11% | -$721K |
2023 Q3
6 quarters
|
|
15
ASML
ASML
$714B
| $6.15M | 3.02% |
9,277
-3,441
| -27% | -$2.5M |
2024 Q4
1 quarter
|
|
16
Pfizer
PFE
$156B
| $6.12M | 3.01% |
241,581
-78,388
| -24% | -$2.05M |
2023 Q4
5 quarters
|
|
17
Microsoft
MSFT
$3.9T
| $6.06M | 2.98% |
16,145
-5,342
| -25% | -$2.18M |
2013 Q2
47 quarters
|
|
18
Biogen
BIIB
$33B
| $6.02M | 2.96% |
44,025
+959
| +2% | +$137K |
2019 Q4
21 quarters
|
|
19
Nike
NKE
$50.4B
| $5.9M | 2.91% |
93,011
-20,244
| -18% | -$1.49M |
2024 Q1
4 quarters
|
|
20
Campbell Soup
CPB
$5.76B
| $4.14M | 2.04% |
103,772
-37,568
| -27% | -$1.47M |
2024 Q1
4 quarters
|
|
21
Verizon
VZ
$190B
| $4.13M | 2.03% |
90,959
-50,006
| -35% | -$2.08M |
2019 Q4
21 quarters
|
|
|
22
Constellation Brands
STZ
$19.4B
| $4.03M | 1.98% |
21,968
+20,697
| +1,628% | +$3.76M |
2020 Q4
17 quarters
|
|
23
Conagra Brands
CAG
$6.3B
| $4.03M | 1.98% |
151,149
-40,266
| -21% | -$1.04M |
2021 Q3
14 quarters
|
|
24
Comcast
CMCSA
$76.5B
| $4.01M | 1.97% |
108,575
-40,348
| -27% | -$1.46M |
2020 Q4
17 quarters
|
|
25
Walt Disney
DIS
$179B
| $3.98M | 1.96% |
40,310
-27,755
| -41% | -$2.98M |
2022 Q4
9 quarters
|
|
Similar funds
PA
WA
EWP
FFG
AA
SWM
GI
ACM
Hillman Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Hillman Capital Management held 57 positions worth $203M, down 25% from $270M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Hillman Capital Management withdrew a net $62.6M in Q1 2025, closing 6 positions and reducing 36 holdings. Its most notable exit was Amazon, an estimated $10.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 20% a quarter earlier, followed by Consumer Staples and Communication Services.
Against the trend, Hillman Capital Management opened a new position in Hershey worth $3.73M.
- Hillman Capital Management's largest Q1 2025 buy was Hershey: 21,808 shares worth $3.73M.
- Hillman Capital Management added most to Microchip Technology in Q1 2025, an estimated $3.98M increase.
- Hillman Capital Management's biggest Q1 2025 reduction was AT&T, cutting an estimated $4.69M.
- Hillman Capital Management fully exited Amazon in Q1 2025, selling an estimated $10.7M.
- Hillman Capital Management's ten largest holdings make up 33% of its $203M portfolio in Q1 2025.
- Hillman Capital Management opened 3 new positions and closed 6 in Q1 2025.
- Hillman Capital Management's portfolio value fell 25% quarter-over-quarter to $203M.
Based on Hillman Capital Management's 13F filing for Q1 2025, filed 15 May 2025.